Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC) (PROTEON).

NCT05602259 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Liege as lead sponsor.

NCT NCT05602259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05602259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC) (PROTEON).
Lead sponsor
Centre Hospitalier Universitaire de Liege
Phase
Not applicable
Overall status
Unknown status
Start date
October 27, 2022
Completion date
May 1, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer